| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Paul Peter Tak | |
| P921 | main subject | rheumatoid arthritis | Q187255 |
| P304 | page(s) | 3242-3247 | |
| P577 | publication date | 2004-09-01 | |
| P1433 | published in | Frontiers in Bioscience | Q5506062 |
| P1476 | title | IFN-beta in rheumatoid arthritis | |
| P478 | volume | 9 |
| Q36360719 | Arthritis and bursitis in multiple sclerosis patients treated with interferon-beta |
| Q33284147 | Arthritis suppression by NADPH activation operates through an interferon-beta pathway |
| Q28271779 | Association of the response to tumor necrosis factor antagonists with plasma type I interferon activity and interferon-beta/alpha ratios in rheumatoid arthritis patients: a post hoc analysis of a predominantly Hispanic cohort |
| Q33521311 | Autoimmune disease classification by inverse association with SNP alleles |
| Q36465497 | Cells of the synovium in rheumatoid arthritis. Macrophages |
| Q28260631 | Constitutive type I interferon modulates homeostatic balance through tonic signaling |
| Q34456715 | Cytokine-modulating strategies and newer cytokine targets for arthritis therapy |
| Q37387713 | Cytokines in Sjögren's syndrome |
| Q34188481 | Gene expression analysis of rheumatoid arthritis synovial lining regions by cDNA microarray combined with laser microdissection: up-regulation of inflammation-associated STAT1, IRF1, CXCL9, CXCL10, and CCL5. |
| Q36955331 | Identification of intra-group, inter-individual, and gene-specific variances in mRNA expression profiles in the rheumatoid arthritis synovial membrane. |
| Q64941403 | Induction or aggravation of other immune-mediated disorders by disease-modifying therapy in treatment of multiple sclerosis. |
| Q39403634 | Norkurarinol inhibits toll-like receptor 3 (TLR3)-mediated pro-inflammatory signaling pathway and rotavirus replication |
| Q21195364 | Overview of the biology of type I interferons |
| Q35673189 | Preclinical Potency and Biodistribution Studies of an AAV 5 Vector Expressing Human Interferon-β (ART-I02) for Local Treatment of Patients with Rheumatoid Arthritis |
| Q35684207 | Prolonged tumor necrosis factor α primes fibroblast-like synoviocytes in a gene-specific manner by altering chromatin. |
| Q28290930 | Relationship between the type I interferon signature and the response to rituximab in rheumatoid arthritis patients |
| Q35953527 | Rheumatoid arthritis subtypes identified by genomic profiling of peripheral blood cells: assignment of a type I interferon signature in a subpopulation of patients. |
| Q42633541 | Right drug, right patient, right time: aspiration or future promise for biologics in rheumatoid arthritis? |
| Q90415127 | The clinical utility of gene expression examination in rheumatology |
| Q38004932 | Type I IFN-mediated regulation of IL-1 production in inflammatory disorders. |
| Q37838003 | Type I interferon in organ-targeted autoimmune and inflammatory diseases |
Search more.